Status: Recruiting
Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/Absence of the Right Heart
The purpose of the study is to monitor the clinical safety and performance of the EXCOR Venous Cannula in context of an EXCOR VAD therapy to ensure continued acceptability of identified risks, to enable detecting emerging risks and to assess clinical improvement on both short- and long-term.
Participants needed: 20
Trial details
Biological sex: AllType: ObservationalSponsor: Berlin Heart GmbHUpdated: Feb 17, 2025Locations: 1Duration: 12 Months
Eligibility criteria
Patient or his/her parent/guardian or legally authorized representative has give... [+3]
Patient or his/her parents/legal guardian or legally authorized guardian has not... [+1]